As per our report, the global specialty enzymes market size is estimated to grow at a CAGR of 9.1% from 2021 to 2026.
Specialty enzymes function as biocatalysts in pharmaceutical and diagnostic processes to speed up reactions and achieve the desired outcomes. Because of their catalytic activity, these enzymes are being utilized for a variety of illnesses. Specialty enzymes have been used in analytical, manipulative, medicinal, and industrial areas. It may be utilized for defection to detection with these applications. In addition, it has the ability to destroy disease-causing microbes, promotes wound healing, and diagnose some illnesses. Specialty enzymes are also widely utilized in the production of medicines to cure a variety of deadly illnesses.
The growth of the global specialty enzymes market is majorly fuelled by the growing use of specialty enzymes for disease diagnosis.
The increasing use of specialty enzymes for disease diagnostics is a major driver of the global specialty enzymes market. The activity of an enzyme that is sensitive to a person's health can aid in the diagnosis and analysis of biological problems. On the other hand, Enzymes are employed to detect changes in substrate concentrations, which indicate biological abnormalities. For example, Lactate Dehydrogenase (LDH) changes in the blood or the use of cholesterol oxidase for cholesterol measurement can assist in diagnosing cardiovascular illnesses or high blood pressure. Enzymes can be used to detect and assess glucose levels in the bloodstream. The amount of glucose in the blood and urine is used to diagnose diabetes. In addition, specialty enzymes are used in various diagnostic applications, including DNA modification and sequencing. As a result, the FDA has allowed 23andMe, a home DNA testing business, to directly sell its gene tests for 10 disorders, including Parkinson's disease, Alzheimer's disease, and several uncommon blood ailments. Furthermore, as the need for healthcare specialty enzymes grows, so does the usage of tests and methods. For example, Enzyme-Linked Immunosorbent Assay (ELISA) procedures frequently include ß-galactosidase, peroxidase, and alkaline phosphatase. As a result, the need for healthcare specialty enzymes is quickly growing.
The rising prevalence of metabolic disorders further drives the growth rate of the global specialty enzymes market.
The growing prevalence of illnesses linked to metabolism is fuelling the market for specialty enzymes. The increased understanding of enzymes in recent years has increased the need for enzymes to treat various illnesses. Familial hypercholesterolemia, Gaucher disease, liver cirrhosis, Krabbe disease, Metachromatic leukodystrophy, Mitochondrial encephalopathy, diabetes, stroke-like episodes (MELAS), Niemann-Pick disease, Phenylketonuria (PKU), heart disease, Tay-Sachs disease, and Wilson's disease are some of the conditions that can be treated with it. In addition, a metabolic syndrome is a group of diseases that develop in tandem and raise your risk of heart disease, stroke, and type 2 diabetes. Increased blood pressure, excessive blood sugar, extra body fat around the waist, and abnormal cholesterol or triglyceride levels are all examples of these diseases. Metabolic syndrome presently affects over a billion individuals throughout the world. The need for enzymatic treatments is growing as a result of this growing incidence.
The market for specialty enzymes is expected to benefit from advancements in enzyme engineering.
Nonetheless, advances in enzyme engineering will create lucrative possibilities for the healthcare specialty enzymes market to expand. For example, enzyme engineering is increasingly being used to improve the stability of enzymes. Furthermore, recent advances in protein engineering, particularly the combination of multidisciplinary techniques such as post-translational enzyme modification, structured assisted protein tailoring, and computational modeling approaches, have opened up new scope for more efficient biocatalyst production. These advancements will ensure that healthcare specialty enzymes have a bright future.
The global specialty enzymes market is expected to be hampered by the complexity of preserving specialty enzymes.
However, the market for specialty enzymes is expected to be hampered by the requirement for precise storage conditions (pH and temperature) for specialty enzymes. Because certain enzymes are highly unstable, they should be kept at –20°C or –80°C for any length of time. It is suggested that enzymes be kept in a cold, dry place. Other circumstances, such as a high acidity in the stomach, may make particular enzymes vulnerable.
Impact of COVID-19 on the global specialty enzymes market:
COVID-19 has accelerated the demand for specialty enzymes. The current COVID-19 epidemic is driving up demand for healthcare specialty enzymes throughout the world. These enzymes are crucial for diagnosing covid – 19. For example, to diagnose clinical samples of SARS-CoV-2, the RT-qPCR was developed using RNA extraction and novel methods. Many industrial companies are working on it to develop a cure for coronavirus infections. For example, Richcore Lifesciences, an Indian biotechnology firm, is planned to develop two pivotal enzyme components, which will be used primarily in the COVID-19 diagnostic kits based on Reverse Transcription Polymerase Chain Reaction (RT-PCR).
A nucleic acid amplification test (NAAT) that identifies one or more RNA gene targets unique to the virus is also presently suggested to diagnose acute or current SARS-CoV-2 infection. In addition, this technique may be used to screen symptomatic patients, those who have been exposed to COVID-19, and people who live in a high-prevalence region. As a result, Creative Enzymes, a U.S.-based producer, has expanded its line of healthcare specialty enzymes, recognizing the current usage of NAT and serological testing for COVID-19 diagnosis.
In addition, there has been an increase in research and development activities for healthcare specialty enzymes to address these covid – 19 issues. For example, specialty Enzymes & Probiotics evaluates the safety and efficacy of the health supplements ImmunoSEBTM (systemic enzyme complex) and ProbioSEB CSC3TM (Bacillus probiotics complex) as supplemental therapy in COVID-19 patients with verified mild to moderate disease.
Market Size Available
2020 to 2026
2021 to 2026
By Source, Type, Application, and Region
Various Analyses Covered
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
North America, Europe, Asia Pacific, Latin America, Middle East, and Africa
This research report on the global specialty enzymes market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2026.
Specialty Enzymes Market - By Source:
Based on the source, Due to the unique features produced in enzymes originating from microbes, the Microorganisms segment accounted for a significant proportion of the market in 2020. Fermented microbial enzyme products provide several benefits, including a wide range of pH, temperature, and substrate specificities.
Specialty Enzymes Market - By Type:
Based on the type, the Polymerases and Nucleases segment is expected to dominate the market during the forecast period. The rising usage of the segment in specialist applications such as medicines, research & biotechnology, diagnostics, and biocatalysts is attributable to its rise. In addition, the production of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) polymers is also catalyzed by these enzymes.
Specialty Enzymes Market - By Application:
Based on the application, the pharmaceutical segment is expected to have the greatest CAGR. In the pharmaceutical business, specialty enzymes are mostly used for medication manufacturing, illness diagnosis, or therapy. In addition, increased use of enzymes in treatments for cancer, cardiovascular disease, lysosomal storage disorders, and pain and inflammation control, among other diseases, is fueling market demand.
Specialty Enzymes Market - By Region:
Geographically, the North American market held the highest share in the global specialty enzymes market in 2020. Enzymes are now accessible for a wide range of applications due to rapid developments in this area, and this sector is expected to drive market expansion in the region. Furthermore, due to the development of innovative and better-performing goods and worldwide, this area is expected to be the largest market. As a result, the United States controls a large portion of the North American specialized enzyme market.
In the Specialty Enzymes Market, Europe has the second-largest share. Medicinal enzymes are in more demand as Europe's population ages. Furthermore, as healthcare expenses grow, advanced enzymes such as immobilized enzymes are becoming increasingly popular.
The Asia Pacific specialty enzymes market is projected to be driven by a rise in population and disposable income among consumers in emerging economies such as China and India. However, because of rising per capita healthcare expenditures, increased awareness of enzyme treatment, and a fast-expanding pharmaceutical manufacturing base, the Asia-Pacific region has the largest future development potential.
KEY MARKET PLAYERS:
Key industry players leading the global specialty enzymes market profiled in this report are Bbi Enzymes Ltd., Basf, Codexis Inc., Nagase & Co. Ltd., Life Technologies, Advanced Enzyme Technology Ltd. Affymetrix Inc., Advanced Enzyme Technology Ltd., Amano Enzyme Inc., Roche Holding Ag., and Sanofi S.A.
These players focus on launches, joint ventures and consolidations, and acquisitions to expand their global reach while improving their product portfolio.
RECENT MARKET HAPPENINGS:
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.5 Y-o-Y Growth Analysis, By Source
5.1.6 Market Attractiveness Analysis, By Source
5.1.7 Market Share Analysis, By Source
220.127.116.11 Other Carbohydrases
5.2.4 Polymerases &Nucleases
5.2.7 Specialty Enzymes Used in Pharmaceuticals
5.2.8 Specialty Enzyme Used in Diagnostics
5.2.9 Specialty Enzyme Used For Research & Biotechnology
5.2.10 Y-o-Y Growth Analysis, By Type
5.2.11 Market Attractiveness Analysis, By Type
5.2.12 Market Share Analysis, By Type
18.104.22.168 Enzyme Replacement Therapy
22.214.171.124 Thrombolytic Enzymes
126.96.36.199 Digestive Enzymes
5.3.3 Research & Biotechnology
5.3.6 Y-o-Y Growth Analysis, By Application
5.3.7 Market Attractiveness Analysis, By Application
5.3.8 Market Share Analysis, By Application
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Source
220.127.116.11 By Type
18.104.22.168 By Application
6.1.4 Market Attractiveness Analysis
22.214.171.124 By Geographical Area
126.96.36.199 By Source
188.8.131.52 By Type
184.108.40.206 By Application
6.1.5 Market Share Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By Source
22.214.171.124 By Type
126.96.36.199 By Application
6.2 North America
6.1.2 United States
6.3.6 South Korea
6.5 Latin America
6.4.5 Rest of Latin America
6.6 Middle East & Africa
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Affymetrix Inc.
8.1.2 Source Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 BBI Enzymes Ltd.
8.3 Nagase & Co. Ltd.
8.4 Life Technologies
8.5 Advanced Enzyme Technology Ltd.
8.6 Roche Holding Ag
8.7 Sanofi S.A.
8.8 Codexis Inc.
8.9 Amano Enzyme Inc.
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures